Cargando…
Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer
INTRODUCTION: Real-world evidence derived from electronic health records (EHRs) is increasingly recognized as a supplement to evidence generated from traditional clinical trials. In oncology, tumor-based Response Evaluation Criteria in Solid Tumors (RECIST) endpoints are standard clinical trial metr...
Autores principales: | Griffith, Sandra D., Tucker, Melisa, Bowser, Bryan, Calkins, Geoffrey, Chang, Che-hsu (Joe), Guardino, Ellie, Khozin, Sean, Kraut, Josh, You, Paul, Schrag, Deb, Miksad, Rebecca A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822856/ https://www.ncbi.nlm.nih.gov/pubmed/31140124 http://dx.doi.org/10.1007/s12325-019-00970-1 |
Ejemplares similares
-
Author’s Response to “A Letter in Support of Real-World RECIST”
por: Griffith, Sandra D., et al.
Publicado: (2020) -
Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC
por: Ma, Xinran, et al.
Publicado: (2021) -
A Letter in Support of Real-World RECIST
por: Gajra, Ajeet, et al.
Publicado: (2020) -
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types
por: Torres, Aracelis Z., et al.
Publicado: (2022) -
Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint
por: Curtis, Melissa D., et al.
Publicado: (2018)